Profesyonel çevirmenler, işletmeler, web sayfaları ve erişimin serbest olduğu çeviri havuzlarından.
deferoxamine
deferoxamin
Son Güncelleme: 2014-12-09
Kullanım Sıklığı: 29
Kalite:
Uyarı: Bu hizalama yanlış olabilir..
Böyle düşünüyorsanız lütfen silin.
deferoxamine b
deferoxamin
Son Güncelleme: 2014-12-09
Kullanım Sıklığı: 3
Kalite:
Uyarı: Bu hizalama yanlış olabilir..
Böyle düşünüyorsanız lütfen silin.
b, deferoxamine
deferoxamin
Son Güncelleme: 2014-12-09
Kullanım Sıklığı: 1
Kalite:
Uyarı: Bu hizalama yanlış olabilir..
Böyle düşünüyorsanız lütfen silin.
deferoxamine (product)
deferoxamin
Son Güncelleme: 2014-12-09
Kullanım Sıklığı: 1
Kalite:
Uyarı: Bu hizalama yanlış olabilir..
Böyle düşünüyorsanız lütfen silin.
16% for deferoxamine).
16% deferoxamin).
Son Güncelleme: 2017-04-26
Kullanım Sıklığı: 1
Kalite:
half of deferoxamine dose
polovina dávky deferoxaminu
Son Güncelleme: 2017-04-26
Kullanım Sıklığı: 1
Kalite:
deferoxamine [chemical/ingredient]
deferoxamin
Son Güncelleme: 2014-12-09
Kullanım Sıklığı: 1
Kalite:
Uyarı: Bu hizalama yanlış olabilir..
Böyle düşünüyorsanız lütfen silin.
for patients well managed on deferoxamine
pacienti, u kterých byla zátěž železem úspěšně léčena deferoxamine m
Son Güncelleme: 2017-04-26
Kullanım Sıklığı: 1
Kalite:
the product information of deferoxamine should be consulted.
je třeba si prostudovat informace o přípravku deferoxamin.
Son Güncelleme: 2017-04-26
Kullanım Sıklığı: 1
Kalite:
therefore deferiprone at the recommended dose could be less effective than deferoxamine.
deferipron proto může být v doporučených dávkách méně účinný než deferoxamin.
Son Güncelleme: 2012-04-11
Kullanım Sıklığı: 2
Kalite:
in one study of two-year duration deferiprone was compared to deferoxamine.
v jedné studii trvající dva roky byl deferipron porovnáván s deferoxaminem.
Son Güncelleme: 2012-04-11
Kullanım Sıklığı: 2
Kalite:
the main study of effectiveness compared exjade with deferoxamine in 591 patients with beta thalassaemia major.
hlavní studie účinnosti srovnávala přípravek exjade s deferoxaminem na 591 pacientech s beta thalasémií major.
Son Güncelleme: 2012-04-11
Kullanım Sıklığı: 2
Kalite:
ferriprox is used when deferoxamine (another medicine used to treat iron overload) cannot be used.
přípravek ferriprox se používá, jestliže nemůže být použit deferoxamin (jiný lék používaný pro léčbu nadměrného zatížení železem).
Son Güncelleme: 2012-04-11
Kullanım Sıklığı: 2
Kalite:
ferriprox is indicated for the treatment of iron overload in patients with thalassaemia major when deferoxamine therapy is contraindicated or inadequate.
ferriprox je určen k léčbě zvýšené zátěže železem u pacientů s thalassemia maior, u kterých je léčba deferoxaminem kontraindikovaná nebo nedostatečná.
Son Güncelleme: 2012-04-11
Kullanım Sıklığı: 2
Kalite:
in the initial study comparing ferriprox with deferoxamine, the average blood ferritin levels were similar in the two treatment groups.
v úvodní studii srovnávající přípravek ferriprox s deferoxaminem byly průměrné hladiny feritinu v krvi v obou léčených skupinách podobné.
Son Güncelleme: 2017-04-26
Kullanım Sıklığı: 1
Kalite:
however, there were too few patients in the study to prove whether or not such a schedule is as effective as deferoxamine taken on its own.
počet pacientů účastnících se studie však nebyl dostatečně vysoký, aby bylo možné prokázat, zda je tato střídavá léčba stejně účinná jako podávání samotného deferoxaminu.
Son Güncelleme: 2017-04-26
Kullanım Sıklığı: 1
Kalite:
based on the reported adverse interaction that can occur between deferoxamine and vitamin c, caution should be used when administering deferiprone and vitamin c concurrently.
vzhledem k hlášeným nežádoucím interakcím mezi deferoxaminem a vitaminem c postupujte při současném podávání deferipronu a vitaminu c opatrně.
Son Güncelleme: 2017-04-26
Kullanım Sıklığı: 3
Kalite:
exjade is also indicated for the treatment of chronic iron overload due to blood transfusions when deferoxamine therapy is contraindicated or inadequate in the following patient groups:
exjade je také indikován k léčbě chronického přetížení organismu železem způsobeného transfuzemi krve, kde je léčba deferoxaminem kontraindikována nebo nevhodná u následujících skupin pacientů:
Son Güncelleme: 2017-04-26
Kullanım Sıklığı: 3
Kalite:
an additional study looked at the effectiveness of exjade in 184 patients who could not be treated with deferoxamine, including patients with beta thalassaemia major and with other types of anaemia.
rovněž byla provedena jedna dodatečná studie, která zkoumala účinnost přípravku exjade u 184 pacientů, kteří nemohli být léčeni deferoxaminem, včetně pacientů s beta-talasemií major a s jinými typy anémie.
Son Güncelleme: 2017-04-26
Kullanım Sıklığı: 1
Kalite:
however, the average iron concentration in the liver of ferriprox- treated patients seemed to increase more than in deferoxamine-treated patients.
zdálo se však, že průměrná koncentrace železa v játrech pacientů léčených přípravkem ferriprox se zvýšila více než u pacientů léčených deferoxaminem.
Son Güncelleme: 2017-04-26
Kullanım Sıklığı: 1
Kalite: